查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828133

2025年原位雜合反應全球市場報告

In Situ Hybridization Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，原位雜合反應市場呈現強勁成長勢頭，市場規模從2024年的16.8億美元成長至2025年的18.1億美元，複合年成長率達8.1%。這段時期的成長可歸因於早期研究的採用、分子生物學工具的不斷發展、診斷應用的開發、生物醫學研究重點的轉變以及生物技術投資的不斷增加。

預計未來幾年原位雜合反應市場規模將快速成長，到2029年將達到27.6億美元，複合年成長率為11.1%。預測期內的成長可歸因於臨床診斷應用的不斷成長、研發資金的增加、自動化和高通量解決方案的出現，以及在神經科學和病理學領域應用的不斷拓展。預測期內的主要趨勢包括分子生物學的進步、研究應用需求的不斷成長、診斷應用的不斷拓展、個人化醫療的需求以及生物醫學研究資金的不斷增加。

原位雜合反應是一種能夠精確定位組織切片中特定核酸片段的技術。此技術可用於識別組織（包括完整組織、組織切片和單一細胞）中的核苷酸序列。

原位雜合反應產品的主要類型包括分析儀器、套件和試劑以及軟體和服務。分析儀器旨在幫助研究人員檢測和可視化細胞和組織內的特定核酸序列。此過程涉及的各種技術包括螢光原位雜合反應(FISH) 和顯色原位雜合反應(CISH)，它們使用不同類型的探針，例如 DNA 和 RNA。這些技術應用於各個領域，包括癌症研究、細胞遺傳學、發育生物學和感染疾病。這些產品的最終用戶包括研究和診斷實驗室、受託研究機構(CRO) 和學術機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供原位雜合反應市場統計數據，例如原位雜合反應行業的全球市場規模、各地區市場佔有率、雜合反應的市場佔有率、原位雜合反應市場細分、市場趨勢和機遇，以及您在原位雜合反應行業取得成功所需的數據。本原位雜合反應市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年11.1%的預測成長率比我們先前對該市場的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自日本和瑞士等主要地區的螢光去氧核糖核酸(DNA) 探針和自動染色平台徵收關稅直接影響美國，從而導致基因檢測結果延遲，並增加癌症和遺傳疾病診斷的成本。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，其影響將更加廣泛。

預計感染疾病的增加將在未來幾年推動原位雜合反應市場的成長。感染疾病是一種病理狀況，可透過病毒、細菌、真菌和寄生蟲等病原體以及受污染的食物和飲料在人與人之間傳播。原位雜合反應(ISH) 使用特異性傳染性生物的標記核酸序列（探針）來檢測組織樣本中的互補核酸序列。因此，感染疾病的增加促進了原位雜合反應市場的擴張。例如，2024 年 3 月，美國政府機構疾病管制與預防中心 (CDC) 報告稱，結核病患者人數從 2022 年的 8,320 人增加了 1,295 人，到 2023 年則增加了 9,615 人。因此，感染疾病的日益普及正在推動原位雜合反應市場的成長。

癌症患者數量的快速成長預計將推動原位雜合反應市場的成長。原位雜合反應用於識別癌細胞中的特定基因變異，例如基因擴增、缺失、易位和重排。根據美國癌症協會 (ACS) 的數據，2023 年美國將新增 1,958,310 例癌症病例，並有 609,820 例癌症死亡病例。因此，癌症發生率的上升是推動原位雜合反應市場成長的關鍵因素。

原位雜合反應市場的主要企業正致力於創造創新解決方案，例如 RNA 檢測分析，以促進基因療法的發展。 RNA 檢測分析是一種分子技術，旨在識別和量化樣本中的特定 RNA 分子，使研究人員能夠研究基因表現、病毒感染和各種與 RNA 相關的生物過程。例如，2023 年 1 月，美國生命科學公司 Bio-Techne Corporation 推出了 RNAscope Plus smRNA-RNA 檢測分析。這種先進的原位雜合反應工具能夠同時螢光檢測同一組織切片中的三種目標 RNA 或 RNA 生物標記物以及調節性小 RNA，包括微型RNA (miRNA)。此檢測提供單細胞和亞細胞解析度，使研究人員能夠有效評估新型基因療法和內源性調節 RNA 的生物分佈和功能。此檢測具有可擴展性，可支援大規模研究，可在 Leica Bond Rx 平台上使用，也可作為手動檢測。結合我們專有的 RNAscope 和 miRNAscope 技術，該檢測顯著增強了我們對基因表現和細胞反應的理解，為開發針對遺傳和後天性疾病的個人化基因療法提供了重要的見解。

原位雜合反應市場的主要企業正透過創新產品解決方案提升盈利，例如雜交鍊式反應RNA顯色原位雜合反應（HCR RNA-CISH）。 HCR RNA-CISH是一種高解析度和高靈敏度可視化細胞和組織中RNA分子的技術。 2023年2月，Molecular Instruments (MI) 推出了HCR RNA-CISH，增強了自動化顯色原位雜合反應工作流程。它還原生支援免疫組織化學（IHC）程式碼檢測，並與主流自動化平台完全相容。

2023年1月，美國生命科學公司安捷倫科技公司（Agilent Technologies Inc.）收購了Avida Biomed Inc.，收購金額未揭露。此次收購旨在增強安捷倫在基因組學領域的能力，並擴展其為研究人員提供的創新工具範圍，尤其是在下一代定序和生物分子分析領域。 Avida Biomed是一家總部位於美國的生物技術公司，專注於開發用於各種醫療應用的尖端診斷解決方案和檢測方法。

原位雜合反應市場的主要企業包括 Thermo Fisher Scientific Inc.、Bio SB Inc.、BioGenex Laboratories、Advanced Cell Diagnostics Inc.、Exiqon A/S、Agilent Technologies Inc.、F. Hoffmann-La Roche AG、Abbott Laboratories Inc.、Merck KGaA、Perkind LLC.S. Nussloch GmbH、Bio-Rad Laboratories Inc.、Oxford Gene Technology、Abnova Corporation、Qiagen、Bio-Techne Corporation、Biochain Institute Inc.、Cytocell Ltd.、Enzo Life Sciences Inc.、Eurofins Scientific SE、FISH Technologies Sdn Bhd 和 Gene Biotech Asia Pvt。 Ltd.、Zytomed System GmbH、Akoya Biosciences Inc.、Becton Dickinson and Company (BD)、DAKO Systemtechnik und Service GmbH GmbH & Co、Molecular Devices LLC.、NanoString Technologies Inc. 與 Visiopharm A/S。

2024年，北美是原位雜合反應市場最大的地區。預計預測期內，亞太地區將成為全球原位雜合反應市場成長最快的地區。原位雜合反應市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

原位雜合反應市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

原位雜合反應市場包括使用合成寡核苷酸探針、雙鏈DNA (dsDNA)探針和單鏈DNA (dsDNA)探針提供原位雜合反應的營業單位所獲得的收益。市場規模還包括服務供應商銷售或包含在其服務產品中的相關產品的價值。原位雜合反應市場還包括線性雜合反應鍊式反應和非線性雜合反應鍊式反應技術的銷售。該市場的價值是指“出廠價”，即產品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球原位雜合反應：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球原位雜合反應市場：成長率分析
  • 全球原位雜合反應市場表現：規模與成長，2019-2024
  • 全球原位雜合反應市場預測：規模與成長，2024-2029，2034
  • 全球原位雜合反應：總目標市場（TAM）

第6章 市場細分

  • 全球原位雜合反應市場（按產品、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 分析設備
  • 套件和試劑
  • 軟體和服務
  • 其他
  • 全球原位雜合反應市場技術、效能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 螢光原位雜合反應（FISH）
  • 顯色原位雜合反應（CISH）
  • 全球原位雜合反應市場（按探針、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）
  • 核糖核酸（RNA）
  • 全球原位雜合反應市場的應用、效能與預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 細胞遺傳學
  • 發育生物學
  • 感染疾病
  • 其他
  • 全球原位雜合反應市場最終用途、性能及預測（2019-2024、2024-2029、2034）
  • 研究和診斷實驗室
  • 合約研究組織（CRO）
  • 學術機構
  • 其他
  • 全球原位雜合反應市場：分析儀器細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 螢光顯微鏡
  • 影像系統
  • 雜合反應系統
  • 全球原位雜合反應市場：套件和試劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 雜合反應套件
  • 檢測試劑套件
  • 探針和試劑
  • 全球原位雜合反應市場：軟體和服務細分、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 影像分析軟體
  • 資料管理軟體
  • 諮詢和支援服務
  • 全球原位雜合反應市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 配件
  • 對照樣品
  • 維護用品

第7章 區域和國家分析

  • 全球原位雜合反應市場各地區、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 全球原位雜合反應市場（依國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 原位雜合反應市場：競爭格局
  • 原位雜合反應市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Bio SB Inc.
    • BioGenex Laboratories
    • Advanced Cell Diagnostics Inc.
    • Exiqon A/S

第31章：其他領先和創新企業

  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Biocare Medical LLC
  • Genemed BIoTechnologies
  • Danaher Corporation
  • Leica Biosystems Nussloch GmbH
  • Bio-Rad Laboratories Inc.
  • Oxford Gene Technology
  • Abnova Corporation
  • Qiagen
  • Bio-Techne Corporation
  • Biochain Institute Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年雜合反應市場：提供新機會的國家
  • 2029年原位雜合反應市場：細分領域帶來新機會
  • 原位雜合反應市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24224u

In-situ hybridization is a method that facilitates the precise localization of a specific nucleic acid segment within a histologic slice. This technique is employed for identifying sequences of nucleotides in tissues, encompassing complete tissues, portions of tissues, and individual cells.

The primary types of in-situ hybridization products include analytical instruments, kits and reagents, software and services, among others. Analytical instruments are designed to assist researchers in detecting and visualizing specific nucleic acid sequences within cells or tissues. Various techniques involved in this process include fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH), which utilize different types of probes such as DNA and RNA. These techniques find applications in diverse areas, including cancer research, cytogenetics, developmental biology, infectious diseases, and more. The end users of these products include research and diagnostic laboratories, contract research organizations (CROs), academic institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The in situ hybridization market research report is one of a series of new reports from The Business Research Company that provides in situ hybridization market statistics, including in situ hybridization industry global market size, regional shares, competitors with an in situ hybridization market share, detailed in situ hybridization market segments, market trends and opportunities, and any further data you may need to thrive in the in situ hybridization industry. This in situ hybridization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in situ hybridization market size has grown strongly in recent years. It will grow from $1.68 billion in 2024 to $1.81 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to early adoption in research, evolution of molecular biology tools, diagnostic applications development, shift in biomedical research focus, increasing investment in biotechnology.

The in situ hybridization market size is expected to see rapid growth in the next few years. It will grow to $2.76 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing adoption in clinical diagnostics, growth in research and development funding, automation and high-throughput solutions, expanded applications in neuroscience and pathology. Major trends in the forecast period include advancements in molecular biology, rising demand in research applications, diagnostic applications expansion, demand for personalized medicine, increased funding in biomedical research.

The forecast of 11.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fluorescent deoxyribonucleic acid (DNA) probes and automated staining platforms, sourced from key regions such as Japan and Switzerland, which could lead to delayed genetic testing results and increased costs for cancer and genetic disorder diagnostics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in infectious diseases is projected to drive the growth of the in-situ hybridization market in the coming years. Infectious diseases are conditions that can be transmitted from one person to another through contaminated food and beverages, as well as through pathogens such as viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) aims to detect complementary nucleic acid sequences in tissue samples by using labeled nucleic acid sequences (probes) that are specific to the infectious organism. Thus, a rise in infectious diseases contributes to the expansion of the in-situ hybridization market. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the growing prevalence of infectious diseases is fueling the growth of the in-situ hybridization market.

The upsurge in cancer cases is anticipated to fuel the growth of the in-situ hybridization market. In-situ hybridization is employed to identify specific genetic alterations in cancer cells, including gene amplifications, deletions, translocations, and rearrangements. According to the American Cancer Society (ACS), it is projected that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. Hence, the increasing incidence of cancer is a significant factor contributing to the growth of the in-situ hybridization market.

Key players in the in situ hybridization market are concentrating on creating innovative solutions, such as RNA detection assays, to enhance the development of gene therapies. An RNA detection assay is a molecular technique designed to identify and quantify specific RNA molecules within a sample, allowing for the examination of gene expression, viral infections, and various RNA-related biological processes. For example, in January 2023, Bio-Techne Corporation, a life sciences company based in the U.S., introduced the RNAscope Plus smRNA-RNA detection assay. This advanced in situ hybridization tool enables the simultaneous fluorescent detection of small regulatory RNAs, including microRNAs (miRNAs), alongside three target RNAs or RNA biomarkers within the same tissue section. The assay offers single-cell and subcellular resolution, allowing researchers to evaluate the biodistribution and functionality of novel gene therapies and endogenous regulatory RNAs effectively. It is designed for scalability to support large-scale studies and can be used on the Leica Bond Rx platform or as a manual assay. By combining proprietary RNAscope and miRNAscope technologies, this assay significantly enhances the understanding of gene expression and cellular responses, providing essential insights for the development of personalized gene therapies for both inherited and acquired diseases.

Major companies operating in the in-situ hybridization market are driving profitability through innovative product solutions, such as Hybridization Chain Reaction RNA Chromogenic in situ Hybridization (HCR RNA-CISH). HCR RNA-CISH is a technique that facilitates the visualization of RNA molecules in cells and tissues with high resolution and sensitivity. In February 2023, Molecular Instruments (MI) launched HCR RNA-CISH to enhance automated chromogenic in-situ hybridization workflows, providing better performance than existing approaches with reduced turnaround time and cost. It also features native support for Immunohistochemistry (IHC) codetection and full compatibility with major automation platforms.

In January 2023, Agilent Technologies Inc., a life sciences company based in the U.S., acquired Avida Biomed Inc. for an undisclosed sum. This acquisition is intended to bolster Agilent's capabilities in genomics and broaden its range of innovative tools for researchers, especially in next-generation sequencing and biomolecular analysis. Avida Biomed Inc. is a U.S.-based biotechnology firm that focuses on creating cutting-edge diagnostic solutions and assays for a variety of medical applications.

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market duirng the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the in situ hybridization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The In-situ hybridization market includes revenues earned by entities by providing in-situ hybridization with synthetic oligonucleotides probes, double-stranded DNA (dsDNA) probes, and single-stranded DNA (dsDNA) probes. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-situ hybridization market also includes sales of linear hybridization chain reaction techniques and non-linear hybridization chain reaction techniques. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Situ Hybridization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in situ hybridization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in situ hybridization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in situ hybridization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Analytical Instruments; Kits and Reagents; Software and Services; Other Products
  • 2) By Technique: Fluorescence In Situ Hybridization (FISH); Chromogenic In Situ hybridization (CISH)
  • 3) By Probe: Deoxyribonucleic Acid (DNA); Ribonucleic Acid (RNA)
  • 4) By Application: Cancer; Cytogenetics; Developmental Biology; Infectious Diseases; Other Applications
  • 5) By End Use: Research And Diagnostic Laboratories; Contract Research Organization (CROs); Academic Institutes; Other End Uses
  • Subsegments:
  • 1) By Analytical Instruments: Fluorescence Microscopes; Imaging Systems; Hybridization Systems
  • 2) By Kits and Reagents: Hybridization Kits; Detection Kits; Probes And Reagents
  • 3) By Software and Services: Image Analysis Software; Data Management Software; Consulting And Support Services
  • 4) By Other Products: Accessories; Control Samples; Maintenance Supplies
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Bio SB Inc.; BioGenex Laboratories; Advanced Cell Diagnostics Inc.; Exiqon A/S; Agilent Technologies Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; Biocare Medical LLC; Genemed Biotechnologies; Danaher Corporation; Leica Biosystems Nussloch GmbH; Bio-Rad Laboratories Inc.; Oxford Gene Technology; Abnova Corporation; Qiagen; Bio-Techne Corporation; Biochain Institute Inc.; Cytocell Ltd.; Enzo Life Sciences Inc.; Eurofins Scientific SE; FISH Technologies Sdn Bhd; Genetix Biotech Asia Pvt. Ltd.; Zytomed System GmbH; Akoya Biosciences Inc.; Becton Dickinson and Company (BD); DAKO Systemtechnik und Service GmbH & Co; Molecular Devices LLC.; NanoString Technologies Inc.; Visiopharm A/S
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Situ Hybridization Market Characteristics

3. In Situ Hybridization Market Trends And Strategies

4. In Situ Hybridization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Situ Hybridization Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Situ Hybridization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Situ Hybridization Market Growth Rate Analysis
  • 5.4. Global In Situ Hybridization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Situ Hybridization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Situ Hybridization Total Addressable Market (TAM)

6. In Situ Hybridization Market Segmentation

  • 6.1. Global In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analytical Instruments
  • Kits and Reagents
  • Software and Services
  • Other Products
  • 6.2. Global In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescence In Situ Hybridization (FISH)
  • Chromogenic In Situ hybridization (CISH)
  • 6.3. Global In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA)
  • Ribonucleic Acid (RNA)
  • 6.4. Global In Situ Hybridization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Cytogenetics
  • Developmental Biology
  • Infectious Diseases
  • Other Applications
  • 6.5. Global In Situ Hybridization Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research And Diagnostic Laboratories
  • Contract Research Organization (CROs)
  • Academic Institutes
  • Other End Uses
  • 6.6. Global In Situ Hybridization Market, Sub-Segmentation Of Analytical Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescence Microscopes
  • Imaging Systems
  • Hybridization Systems
  • 6.7. Global In Situ Hybridization Market, Sub-Segmentation Of Kits and Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hybridization Kits
  • Detection Kits
  • Probes And Reagents
  • 6.8. Global In Situ Hybridization Market, Sub-Segmentation Of Software and Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Image Analysis Software
  • Data Management Software
  • Consulting And Support Services
  • 6.9. Global In Situ Hybridization Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Accessories
  • Control Samples
  • Maintenance Supplies

7. In Situ Hybridization Market Regional And Country Analysis

  • 7.1. Global In Situ Hybridization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Situ Hybridization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Situ Hybridization Market

  • 8.1. Asia-Pacific In Situ Hybridization Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Situ Hybridization Market

  • 9.1. China In Situ Hybridization Market Overview
  • 9.2. China In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Situ Hybridization Market

  • 10.1. India In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Situ Hybridization Market

  • 11.1. Japan In Situ Hybridization Market Overview
  • 11.2. Japan In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Situ Hybridization Market

  • 12.1. Australia In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Situ Hybridization Market

  • 13.1. Indonesia In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Situ Hybridization Market

  • 14.1. South Korea In Situ Hybridization Market Overview
  • 14.2. South Korea In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Situ Hybridization Market

  • 15.1. Western Europe In Situ Hybridization Market Overview
  • 15.2. Western Europe In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Situ Hybridization Market

  • 16.1. UK In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Situ Hybridization Market

  • 17.1. Germany In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Situ Hybridization Market

  • 18.1. France In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Situ Hybridization Market

  • 19.1. Italy In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Situ Hybridization Market

  • 20.1. Spain In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Situ Hybridization Market

  • 21.1. Eastern Europe In Situ Hybridization Market Overview
  • 21.2. Eastern Europe In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Situ Hybridization Market

  • 22.1. Russia In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Situ Hybridization Market

  • 23.1. North America In Situ Hybridization Market Overview
  • 23.2. North America In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Situ Hybridization Market

  • 24.1. USA In Situ Hybridization Market Overview
  • 24.2. USA In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Situ Hybridization Market

  • 25.1. Canada In Situ Hybridization Market Overview
  • 25.2. Canada In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Situ Hybridization Market

  • 26.1. South America In Situ Hybridization Market Overview
  • 26.2. South America In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Situ Hybridization Market

  • 27.1. Brazil In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Situ Hybridization Market

  • 28.1. Middle East In Situ Hybridization Market Overview
  • 28.2. Middle East In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Situ Hybridization Market

  • 29.1. Africa In Situ Hybridization Market Overview
  • 29.2. Africa In Situ Hybridization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In Situ Hybridization Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In Situ Hybridization Market, Segmentation By Probe, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Situ Hybridization Market Competitive Landscape And Company Profiles

  • 30.1. In Situ Hybridization Market Competitive Landscape
  • 30.2. In Situ Hybridization Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bio SB Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BioGenex Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Advanced Cell Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Exiqon A/S Overview, Products and Services, Strategy and Financial Analysis

31. In Situ Hybridization Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. F. Hoffmann-La Roche AG
  • 31.3. Abbott Laboratories Inc.
  • 31.4. Merck KGaA
  • 31.5. PerkinElmer Inc.
  • 31.6. Biocare Medical LLC
  • 31.7. Genemed Biotechnologies
  • 31.8. Danaher Corporation
  • 31.9. Leica Biosystems Nussloch GmbH
  • 31.10. Bio-Rad Laboratories Inc.
  • 31.11. Oxford Gene Technology
  • 31.12. Abnova Corporation
  • 31.13. Qiagen
  • 31.14. Bio-Techne Corporation
  • 31.15. Biochain Institute Inc.

32. Global In Situ Hybridization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Situ Hybridization Market

34. Recent Developments In The In Situ Hybridization Market

35. In Situ Hybridization Market High Potential Countries, Segments and Strategies

  • 35.1 In Situ Hybridization Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In Situ Hybridization Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In Situ Hybridization Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer